Previous Article | Next Article 
Journal of Virology, May 1999, p. 3818-3825, Vol. 73, No. 5
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Virus Promoters Determine Interference by Defective
RNAs: Selective Amplification of Mini-RNA Vectors and Rescue from
cDNA by a 3' Copy-Back Ambisense Rabies Virus
Stefan
Finke and
Karl-Klaus
Conzelmann*
Department of Clinical Virology, Federal
Research Centre for Virus Diseases of Animals, D-72076
Tübingen, and Max von Pettenkofer Institut, Genzentrum,
D-81377 Munich, Germany
Received 21 September 1998/Accepted 1 February 1999
 |
ABSTRACT |
Typical defective interfering (DI) RNAs are more successful in the
competition for viral polymerase than the parental (helper) virus,
which is mostly due to an altered DI promoter composition. Rabies virus
(RV) internal deletion RNAs which possess the authentic RV terminal
promoters, and which therefore are transcriptionally active and can be
used as vectors for foreign gene expression, are poorly propagated in
RV-infected cells and do not interfere with RV replication. To allow
DI-like amplification and high-level gene expression from such mini-RNA
vectors, we have used an engineered 3' copy-back (ambisense) helper RV
in which the strong replication promoter of the antigenome was
replaced with the 50-fold-weaker genome promoter. In cells
coinfected with ambisense helper virus and mini-RNAs encoding
chloramphenicol acetyltransferase (CAT) and luciferase, mini-RNAs were
amplified to high levels. This was correlated with interference with
helper virus replication, finally resulting in a clear predominance of
mini-RNAs over helper virus. However, efficient successive
passaging of mini-RNAs and high-level reporter gene activity could be
achieved without adding exogenous helper virus, revealing a rather
moderate degree of interference not precluding substantial HV
propagation. Compared to infections with recombinant RV vectors
expressing CAT, the availability of abundant mini-RNA templates
led to increased levels of CAT mRNA such that CAT activities were
augmented up to 250-fold, while virus gene transcription was kept to a
minimum. We have also exploited the finding that internal deletion
model RNAs behave like DI RNAs and are selectively amplified in the
presence of ambisense helper virus to demonstrate for the first
time RV-supported rescue of cDNA after transfection of mini-RNA cDNAs
in ambisense RV-infected cells expressing T7 RNA polymerase.
 |
INTRODUCTION |
The genetic information of
nonsegmented negative-strand RNA viruses (order
Mononegavirales) is contained in a ribonucleoprotein complex
(RNP). Both the negative-strand genome RNA, from which all virus genes
are expressed, and the complementary positive-sense antigenome RNA,
which represents the replicative intermediate, are tightly encapsidated
by nucleoprotein (N) and associated with the viral RNA polymerase (L)
and a polymerase cofactor (P). Only RNPs are templates for all viral
RNA synthesis. Genome RNPs may act as templates for transcription of a
short leader RNA and monocistronic mRNAs, as well as for replication of
full-length RNPs which involves cotranscriptional encapsidation. As a
corollary, infection of cells leads to the synthesis of huge amounts of
genome strand RNPs, while antigenome RNPs are found at low levels. In
the case of paramyxoviruses such as Sendai virus, the bias is moderate, with a 4- to 10-fold preponderance of genome RNAs. Very different values have been reported for members of the Rhabdoviridae
family. Whereas a modest three- to fourfold predominance of genome RNPs was observed in vesicular stomatitis virus (VSV)-infected cells, the ratios between genome and antigenome RNAs may reach 50:1 in rabies virus (RV)-infected cells (genus Lyssavirus of the
Rhabdoviridae family) (15).
The observed biases have been attributed to different activities of the
cis-acting sequences present at the 3' end of the genome and
antigenome RNAs, respectively, which are required to direct replication
and encapsidation (5, 6, 9, 12, 28, 30, 31, 34, 45, 46).
Since the sequences engaged in the different functions, such as
polymerase binding, replication initiation and enhancement,
encapsidation, and elongation, are poorly defined, these RNA ends are
so far regarded as the genome promoter (GP) and the antigenome promoter
(AGP), respectively (5). Accordingly, the AGP should
represent a strong replication promoter, whereas the GP should function
as a weak replication promoter. This view was first supported by the
structure of naturally occurring defective interfering (DI) RNAs of VSV
and paramyxoviruses (36, 37). Most of the DI RNAs which
replicated efficiently while heavily interfering with helper virus (HV)
replication were of the so-called 5' copy-back type, containing a copy
of the strong AGP at both RNA ends. In contrast, RV internal deletion
RNAs containing the promoter sequences of the original virus, i.e., one
copy of the GP and one copy of the AGP, replicate less efficiently, and interference with virus replication is not observed (9, 41).
Since the GP is active not only in replication but also in the
synthesis of a leader RNA and transcription of subgenomic RNAs, a
competition between replication and transcription might contribute to
the apparently weak replication capacity of the GP. Although this
cannot be totally ruled out, recent studies support the assumption that
the two promoter sequences indeed differ in the ability to serve as an
initiation site for RNA replication (5, 14, 20, 23, 45).
However, the factors that determine their activity remain incompletely understood.
We previously addressed the function of RV promoters by constructing a
recombinant 3' copy-back virus in which the AGP was replaced with a
copy of the transcriptionally active GP. This virus (SAD Ambi-CAT) was
able to express genes from both RNA strands, thus exhibiting ambisense
gene expression. In SAD Ambi-CAT-infected cells, genome and antigenome
RNAs were present in equal amounts, revealing that the striking 50:1
bias in RV-infected cells is exclusively due to the competition between
the GP and AGP. Most remarkably, the total rate of SAD Ambi-CAT
replication was not much lower than that of RV. Thus, the replication
capacity of the RV GP is not low per se; rather, the GP is competed out
by the stronger AGP in the engagement of a limiting amount of
polymerase (15).
In this study, we examined whether the presence of the parental
AGP in transcriptionally active internal deletion RNAs would allow
successful competition with the replication of an HV of the ambisense
type. We analyzed the propagation and gene expression of
bicistronic model RNAs encoding chloramphenicol acetyltransferase (CAT) and luciferase reporter genes in cells infected with
standard RV or with ambisense RV as the helper. Whereas the mini-RNAs
were poorly replicated and expressed in RV-infected cells, they behaved as true DI RNAs in ambisense virus-infected cells. Preferential amplification of the model RNAs was correlated with interference with
the replication of the ambisense HV. The degree of interference, however, was moderate enough to allow high-level HV-supported reporter
gene expression from the model RNAs throughout successive passages.
In contrast to paramyxoviruses, for which HV-mediated recovery of
artificial RNAs into RNPs is easily achieved, rescue of rhabdovirus-like RNAs by HVs has not been demonstrated. The finding that standard RV RNAs can be rendered the phenotype of DI RNAs by
selecting an appropriate HV led us to reason that ambisense RVs might
not only represent valuable tools for efficient expression of foreign
genes from transcriptionally active mini-RNAs but also allow recovery
of cDNA-derived RNA transcripts. Indeed, after transfection of
plasmids encoding the mini-RNA in T7 RNA polymerase-expressing cells
previously infected with ambisense RV, mini-RNAs were rescued reproducibly.
 |
MATERIALS AND METHODS |
Construction of cDNA clones.
As a basis for the construction
of the bicistronic cDNA plasmid pSDI-CL(NP), we used the previously
described pSDI-CAT, which contains the CAT gene between the cDNA
sequences of the terminal regions of RV (9). For integration
of additional restriction sites, two synthetic oligonucleotides (AdapI
[5'-ctagtgttaacaggcctgcgcgcagatctggctagct-3'] and AdapII
[5'-ctagagctagccagatctgcgcgcaggcctgttaaca-3']) were annealed and inserted as a 37-bp DNA fragment in an XbaI
site downstream of the CAT gene. The downstream XbaI site
was restored and was used after Klenow fill-in for the insertion of the
firefly luciferase gene, which was excised from pT3/T7-luc (Clontech) as a BsmI/SmaI DNA fragment. In a further step,
the two reporter gene sequences were separated by the insertion of an
86-bp MaeIII/AsuII/Klenow DNA fragment (positions
1412 to 1498 of RV SAD B19 [7]) from the RV
full-length cDNA clone pSAD L16 (42), which comprises the
cis-acting transcription signals for N mRNA
stop/polyadenylation and P mRNA start.
For the construction of pSAD Ambi, a DNA fragment comprising the
complete leader RNA sequence and the N start signal of RV SAD B19
(position 1 to 67) was PCR amplified from pSDI-1 (9) with
primer 49M (5'-cgcgcggttaacaggggtgttacatttttgc-3') and
reversed primer (5'-ggaaacagctatgaccatg-3'). The PCR product
was subcloned as a NotI/HpaI DNA fragment in
pSKADAP
(NotI/HpaI). pSKADAP
was generated by insertion of the
synthetic 37-bp DNA fragment described above into the XbaI
site of pBluescript SKII
(Stratagene). The resulting plasmid pleaHpa
contained the RV leader sequence and the N start sequence, followed by
an HpaI restriction site. By replacement of the 1.1-kb
HpaI/NotI fragment of pSAD Ambi-CAT (15), which comprises the CAT reporter gene sequence and the leader sequence with the 0.3-kb HpaI/NotI
fragment of pleaHpa, the cDNA full-length clone pSAD Ambi
(organization, T7 promoter-leader-RV genes-leader-hepatitis delta
virus-T7 terminator) was generated.
For expression of RV proteins N, P, and L in T7 polymerase-expressing
cells, the coding sequences of the RV genes were inserted in the vector
pTIT, which comprises the internal ribosome entry site (IRES) of the
encephalomyocarditis virus (organization, T7 promoter-IRES-multiple
cloning site-T7 terminator [4]). pTIT-N was
constructed by insertion of a 150-bp NcoI/EcoRV
fragment that was PCR amplified from pT7T-N (9) with the
primers N-ATG (5'-aataccatggatgccgacaagattg-3') and N2M
(5'-cccatatagcatcctac-3') in pTIT
(NcoI/EcoRV) and subsequent integration of a
1.3-kb EcoNI/PstI fragment of pT7T-N. pTIT-P was
generated after insertion of a 180-bp BspHI/NcoI
PCR fragment (primers P-ATG [5'aatatcatgagcaagatctttgtca-3']
and NS3M [5'-tccactgatagatcatcc-3']) from pT7T-P
(9) in pTIT (BspHI/NcoI) and
subsequent integration of an
NcoI/ HindIII fragment of pT7T-P. pTIT-L
was constructed by insertion of a 480-bp
SphI/NsiI-digested PCR fragment (primers L-ATG
[5'-agcaggcatgctcgatcctgg-3'] and 6410M
[5'-aagttgactaactttgtctttt-3']) of pT7T-L (9)
in pTIT (NcoI/PstI) and subsequent insertion of a
6.4-kb BsgI/SpeI fragment of pTIT-L.
Cells, viruses, and cDNA rescue experiments.
RV SAD L16
(42) and SAD Ambi-CAT (15) were grown on BSR (a
BHK-21 clone) cell monolayers. For vaccinia virus-free recovery of RV
or HV-driven recovery of mini-RNAs, we used the BSR T7/5 clone, which
stably expresses T7 RNA polymerase (4).
Infectious SDI-CL(NP) particles were recovered from pSDI-CL(NP) as
described previously for pSDI-CAT (9). Four micrograms of
pSDI-CL(NP) was cotransfected with T7T plasmids encoding the RV
proteins N, P, M, G, and L in BSR cells expressing T7 RNA polymerase from recombinant vTF7-3. Three days after transfection, cell culture supernatants were harvested, partially cleared of vaccinia virus by
centrifugation, and transferred on fresh BSR cells. The cells were
superinfected with helper virus at a multiplicity of infection (MOI) of
1 after 1 h.
The recombinant RV SAD Ambi was recovered in a new, vaccinia virus-free
recovery system, using BSR T7/5 cells that constitutively express T7
RNA polymerase (4). For virus recovery, 10 µg of full-length cDNA and plasmids pTIT-N (5 µg), pTIT-P (2.5 µg), and
pTIT-L (2.5 µg) were cotransfected in BSR T7/5 cells. After 3 days,
fresh cell culture medium was added; after a further 3 days, cell
culture supernatants were harvested and transferred on BSR cells. Two
days after passage, infectious virus was detected by immunostaining
against RV N protein (42). DNA transfections were performed
after CaPO4 precipitation (Stratagene) in 8-cm2
culture dishes containing ~106 cells.
RNA analysis.
Total RNA from cells or from virions pelleted
from supernatants by ultracentrifugation (Beckman TLA45 rotor; 45,000 rpm, 1 h, 4°C) was isolated 2 days after infection with an
RNeasy Mini kit (Qiagen) according to the supplier's instructions.
Agarose gel electrophoresis and Northern blotting were performed as
described previously (8). RV N and CAT DNA fragments were
labeled with [
-32P]dCTP (3,000 Ci/mmol; ICN) by nick
translation (nick translation kit; Amersham). After hybridization, RNA
amounts were measured in a phosphorimager (Fuji-BAS).
Luciferase assay.
Two days after infection, the cell
monolayers were lysed with 1 ml of luciferase lysis buffer, and enzyme
activities in cell extracts were determined as described previously
(41).
 |
RESULTS |
Previous studies on synthetic RV model RNAs have shown that
transcribing internal deletion-type RNAs possessing the authentic parental 3' and 5' ends are replicated inefficiently by wild-type (wt)
helper RV and do not interfere with HV replication (9, 41).
Since in RV-infected cells the AGP directs the synthesis of an
approximately 50-fold-higher amount of RNPs than the GP (15), we reasoned that internal deletion RNAs might be able to successfully compete with an HV containing only GPs, such as the
previously described SAD Ambi-CAT (15).
To study the competition between the two different promoters, we
analyzed the replication activities and gene expression of a
bicistronic model RNA, SDI-CL(NP), in cells coinfected with SAD
Ambi-CAT or with standard RV SAD L16. As for the previously described
monocistronic mini-RNAs SDI-CAT (9) or SDI-flash (41), SDI-CL(NP) contained the authentic RV 3' and 5' ends
(68 and 164 residues, respectively [Fig.
1]) but encoded two nonviral reporter
gene products, CAT and firefly luciferase. The reporter genes were
separated by the N/P gene border sequence of RV strain SAD B19 which
directs transcription termination/polyadenylation of the upstream CAT
mRNA and restart of luciferase mRNA transcription. SDI-CL(NP) was
initially recovered from cDNA in a standard RV recovery system
(9). After infection of BSR cells with recombinant vaccinia
virus vTF7-3 (16), providing T7 RNA polymerase and transfection of T7 promoter-controlled plasmids encoding RV proteins N,
P, M, G, and L and of pSDI-CL(NP), the mini-RNAs were rescued by
encapsidation into RNPs. Supernatants containing SDI-CL(NP) particles
were harvested 3 days after transfection, pooled, and used as a stock
for coinfection experiments.

View larger version (24K):
[in this window]
[in a new window]
|
FIG. 1.
(A) Organization of the RV genome. The RV genes (marked
by filled boxes) are flanked by noncoding sequences, which contain the
terminal promoters for replication and transcription. The 3'-terminal
sequence of the positive-sense RNA comprises the AGP, which is inactive
in transcription but functional in replication as a strong promoter.
The 3' end of the negative-sense genome RNA comprises the
transcriptionally active GP, which is a weak promoter in the
replication mode. (B) Organization of the bicistronic model RNA
SDI-CL(NP). The reporter genes are separated by the N/P gene border
sequence of wt RV, which comprises cis-acting signals for
transcription stop/polyadenylation and restart. As in wt RV, the
terminal RNA sequences consist of the GP and AGP (positions 1 to 68 and
11763 to 11928 of RV SAD B19). (C) Organization of recombinant
ambisense RVs. In SAD Ambi-CAT, the AGP sequence is exchanged for a
copy of the GP sequence and the CAT gene sequence is coded on the
positive-sense RNA strand in orientation opposite that of the RV genes
(15). SAD Ambi lacks the CAT reporter gene.
|
|
Ambisense RV supports high-level gene expression from
mini-RNAs.
In the first DI passage experiment, 106 BSR
cells were infected with identical aliquots of the SDI-CL(NP) particle
stock resulting from rescue experiments. One hour postinfection, the
cells were superinfected with SAD Ambi-CAT or with RV SAD L16 at an MOI
of 1. After 48 h of coinfection, cell culture supernatants were
harvested and 1 ml of supernatant of a total of 2 ml was transferred on fresh BSR cells, without additional HV. Five further passages were
performed according to the same protocol.
Mini-RNA gene expression was first analyzed by monitoring the activity
of the luciferase reporter gene product (Fig.
2). Two days after the initial
coinfection (passage 1), luciferase activities were about 100-fold
higher in cells infected with SAD Ambi-CAT than in cells infected with
SAD L16 HV. Thus, SAD Ambi-CAT supported gene expression from the
mini-RNA much more efficiently than wt RV. During the further passages,
the luciferase activity was greatly increased in SAD Ambi-CAT-infected
cells, whereas SAD L16 allowed only low-level luciferase expression.
From the second passage on, SAD Ambi-CAT yielded
104-fold-higher luciferase expression than SAD L16.
Infection of cells with SAD Ambi-CAT, SAD L16, or SDI-CL(NP) alone did
not result in detectable luciferase activity.

View larger version (30K):
[in this window]
[in a new window]
|
FIG. 2.
Mini-RNA-derived luciferase expression is enhanced in
SAD Ambi-CAT-infected cells. BSR cells were infected with a SDI-CL(NP)
stock and were superinfected with SAD Ambi-CAT or SAD L16 (MOI of 1).
Successive passages were performed by transferring supernatants on
fresh cells every 48 h without adding exogenous HV.
Luciferase activities in cell extracts prepared from each passage
experiment are shown as relative light units per 104
infected cells.
|
|
RNA synthesis of mini-RNAs interferes with HV replication.
The
augmented expression of mini-RNA-encoded luciferase in ambisense
virus-infected cells and the efficient passaging of luciferase activity
indicated that SDI-CL(NP) was used preferentially as a template for RNA
synthesis. To analyze RNA synthesis directly, RNA was isolated from
cells in parallel experiments. Northern hybridization with a
luciferase-specific DNA probe showed that in SAD Ambi-CAT-infected
cells the mini-RNA-encoded luciferase gene was transcribed in large
amounts as a monocistronic mRNA (Fig.
3A). As generally found for RV mRNAs, a
minor fraction of luciferase-specific mRNA was transcribed as a
bicistronic CAT/luciferase mRNA by partial readthrough at the N/P gene
border separating the two reporter genes. Since the bicistronic mRNA
[2.8 kb + poly(A)] and the mini-RNA template (3.1 kb) have
nearly the same length, discrimination of the two RNAs was not possible
in this experiment. In SAD Ambi-CAT-infected cells luciferase
mRNA was readily detectable after the first passage. The level
of luciferase mRNA strongly increased after the second passage and
remained at a high level after the third passage, reflecting
the observed reporter gene activities. Although identical
aliquots of SDI-CL(NP) were used for the initial coinfections
(first passage), luciferase-specific RNA was not detectable in SAD
L16-infected cells after the first passage. Even after loading of 10 times more RNA, only a slight hybridization signal was visible
(not shown). In contrast to SAD Ambi-CAT, SAD L16 HV was not able
to augment the level of mini-RNA-derived transcripts during the
following passage experiments (not shown).

View larger version (32K):
[in this window]
[in a new window]
|
FIG. 3.
SDI-CL(NP) is selectively amplified in SAD
Ambi-CAT-infected cells and interferes with HV replication. BSR cells
were infected with SDI-CL(NP) stock and helper HVs, and passages (1.P,
2.P, and 3.P) were performed as described for Fig. 2. Cell RNA was
analyzed with luciferase (A) and CAT (B) gene-specific DNA probes
recognizing both plus- and minus-strand RNAs. Mini-RNA-derived
luciferase mRNA was detectable in SAD Ambi-CAT-infected cells after the
first passage, in contrast to SAD L16-infected cells. In SAD
Ambi-CAT-infected cells, CAT RNAs are represented by a 1-kb
monocistronic CAT mRNA, derived either from SDI-CL(NP) or from
HV, a 3.1-kb RNA band composed of full-length mini-RNA and
CAT/luciferase (luc) readthrough transcripts, and HV full-length RNA.
The 3.1-kb hybridization signal was detectable after the first passage
and much stronger after the second passage. At the bottom, the ratios
of CAT mRNA and HV RNA are given.
|
|
Due to the presence of the CAT gene in both SAD Ambi-CAT HV and the
mini-RNA, hybridization with a CAT gene-specific DNA probe allowed us
to directly compare HV full-length RNA, full-length SDI-CL(NP) RNA, and
CAT mRNAs (Fig. 3B). An increase in the level of SDI-CL(NP) RNA-derived
RNA was correlated with a striking decrease of HV RNA. Thus, SDI-CL(NP)
interfered heavily with HV replication. The total amount of
monocistronic CAT mRNAs which could be transcribed from both SAD
Ambi-CAT and SDI-CL(NP) was considerably greater in coinfected cells
than in cells infected only with SAD Ambi-CAT. This obviously is due to
the increasing amount of SDI-CL(NP) CAT templates in coinfected cells.
The amount of HV template, which has been shown to represent 50% of
the total full-length RNA of SAD Ambi-CAT (15) and which
must provide all essential RV proteins, was reduced to a strikingly low
level after passage 2 and was not detectable under these hybridization
conditions after passage 3. However, HV levels were maintained high
enough to allow efficient replication of mini-RNAs and highly efficient
passaging of the defective RNAs.
Quantitation of the hybridization signals by phosphorimaging showed
that after the second passage the ratio of monocistronic CAT mRNA to
SAD Ambi-CAT full-length RNA was nearly 1,000:1 in SAD
Ambi-CAT-SDI-CL(NP)-infected cells, whereas it was only 5:1 when cells
were infected with SAD Ambi-CAT alone. Thus, CAT mRNA synthesis
relative to HV full-length RNA was increased approximately 200-fold in
the presence of SDI-CL(NP) compared to SAD Ambi-CAT alone. As for the
luciferase probe, direct quantitation of SDI-CL(NP) RNA was not
possible due to the comigrating bicistronic CAT/luciferase transcript.
However, from other studies (to be published elsewhere) it is known
that in SAD L16-infected cells readthrough at the N/P gene border in
SDI-CL(NP) yields up to 7% of CAT mRNAs. Since the 3.1-kb RNA
hybridization signal reached 15% of the monocistronic CAT mRNA signal,
at least half of the 3.1-kb band represents full-length mini-RNA. This
finding further confirmed that mini-RNA was much more abundant than SAD
Ambi-CAT HV RNA in coinfected cells.
To allow direct comparison, RNA was prepared from supernatant virions,
which do not contain mRNAs. Northern hybridizations reflected the
findings obtained with cell extracts: mini-RNA was detectable after the
first passage and was strongly amplified in the further passages, while
the level of HV RNA was greatly decreased (Fig.
4). In supernatants from the second
passage, the amount of mini-RNA exceeded that of HV by a factor of 240. Due to hardly detectable amounts of HV RNA in the following passages, reliable ratios could not be determined; however, mini-RNAs were kept
at levels comparable to those after passage 2. In contrast to
supernatants from SDI-CL(NP)-infected cells, supernatants from cells
infected only with ambisense HV contained quite stable amounts of HV
RNA throughout the passages. Mini-RNA was not detectable in
supernatants from SAD L16-SDI-CL(NP)-infected cells. Taken together,
these results demonstrate that the internal deletion RNA SDI-CL(NP)
behaves like a DI RNA when SAD Ambi-CAT is used as an HV, whereas it is
not amplified in standard RV-infected cells.

View larger version (42K):
[in this window]
[in a new window]
|
FIG. 4.
Formation of supernatant virions. RNA was isolated from
virion pellets after ultracentrifugation of cell culture supernatants
from passage experiments (Fig. 3) and was analyzed by Northern
hybridization with a CAT gene-specific DNA probe. In all passages with
SAD Ambi-CAT HV, SDI-CL(NP) virion RNA was detectable. With
increasing amounts of mini-RNA, the amount of SAD Ambi-CAT HV decreased
after the passage 2 (2.P) and was not detectable after the passage 3 (3.P). In supernatants from SAD L16/SDI-CL(NP)-infected cells or in
supernatants from cells infected with SDI-CL(NP) alone, mini-RNAs
were not detectable. n.d., not detectable.
|
|
Interference with ambisense HV is not due to the presence of the
additional CAT gene.
After having confirmed the DI phenotype of
SDI-CL(NP) for SAD Ambi-CAT, we wished to exclude the possibility
that the expression of the additional CAT gene from the HV antigenome
somehow contributed to the degree of interference. To this end, we
constructed an ambisense RV from cDNA in which the CAT reporter
gene was deleted (SAD Ambi [Fig. 1]).
SAD Ambi was recovered in a new vaccinia virus-free recovery system
that makes use of T7 RNA polymerase-expressing cells (BSR T7/5
[4]). These cells were transfected with T7
promoter-controlled plasmids encoding RV proteins N, P, and L
downstream of the encephalomyocarditis virus IRES and with pSAD Ambi.
Six days after transfections, the supernatants were transferred onto
fresh BSR cell monolayers (for details, see Materials and Methods).
Virus recovery was monitored 2 days after passage by
immunofluorescence, and the recombinant virus was grown for two further
passages on BSR cells.
Coinfections of SDI-CL(NP) and SAD Ambi were performed as described
above, and cell RNA was prepared after three passages. Hybridizations
with the CAT probe verified that CAT gene-specific RNAs were
synthesized in abundant amounts when cells were additionally infected
with SDI-CL(NP) (Fig. 5). Full-length
SAD Ambi RNA was readily detected with an N probe in cells infected
with SAD Ambi alone, but in coinfections with SDI-CL(NP), full-length
RNA was reduced to levels not detectable with the N probe. However,
HV-derived N transcripts could be demonstrated and were found to be
reduced fourfold in comparison with cells infected with SAD Ambi or SAD Ambi-CAT alone. Thus, SDI-CL(NP) interfered with SAD Ambi as with SAD
Ambi-CAT, confirming that the interference is due exclusively to the
difference in promoter composition of ambisense HVs and mini-RNA.

View larger version (47K):
[in this window]
[in a new window]
|
FIG. 5.
Model RNA-derived gene expression exceeds HV gene
expression. SDI-CL(NP) was passaged with SAD Ambi as described
above for SAD Ambi-CAT. For the third passage, BSR cells were infected
with the HV-DI stock (Ambi; +) at an HV MOI of 1. Cells were also
infected with SAD Ambi alone (Ambi; ) or with SAD Ambi-CAT (Ambi-CAT)
at an MOI of 1. Cell RNA was analyzed by Northern blotting 2 days
postinfection by CAT- and RV N gene-specific DNA probes. In SAD
Ambi-SDI-CL(NP)-coinfected cells, the level of monocistronic CAT
mRNA was 11-fold higher than in cells infected with SAD Ambi-CAT. The
level of N mRNA was fourfold lower in SAD
Ambi-SDI-CL(NP)-coinfected cells than in SAD Ambi- or SAD
Ambi-CAT-infected cells. luc, luciferase.
|
|
In contrast to SAD Ambi-CAT, SAD Ambi HV does not produce CAT mRNA.
However, virtually the same amounts of CAT mRNAs were observed in cells
coinfected with SDI-CL(NP) or with either SAD Ambi or SAD Ambi-CAT,
showing that the contribution of SAD Ambi-CAT to CAT transcription
was negligible. Compared to cells infected with SAD
Ambi-CAT alone, an 11-fold amount of CAT mRNA was determined. Further experiments in which different HV MOIs and incubation times
were used (not shown) revealed that CAT activities may be 40- to
250-fold higher in cells infected with SDI-CL(NP) and SAD-Ambi than
in cells infected with SAD Ambi-CAT alone. We have previously shown
that recombinant RVs expressing a CAT gene from the genome RNA (SAD
XCAT and SAD VCAT [24]) and SAD Ambi-CAT produced
comparable amounts of CAT protein (15). Thus, the described
binary system involving a transcriptionally active DI RNA in
combination with an ambisense HV provides the possibility of expressing
heterologous genes much more efficiently than is possible with standard
recombinant virus vectors. Moreover, while mini-RNA-encoded genes
are expressed preferentially, the expression of HV genes is reduced to
a minimum.
Ambisense helper RV support recovery of mini-RNAs from cDNA.
In striking contrast to paramyxoviruses and orthomyxoviruses, HV-driven
rescue of artificial RNAs into RNPs has not been described for
rhabdoviruses, and own attempts to recover mini-RNAs in RV-infected cells were unsuccessful (unpublished results). The highly preferential amplification of RV mini-RNAs by ambisense HVs prompted us to investigate whether it is possible to demonstrate rescue of mini-RNAs in cells infected with ambisense viruses.
To this end, 106 T7 RNA polymerase-expressing BSR T7/5
cells were infected with SAD Ambi-CAT at an MOI of 1. Twenty hours
postinfection, the cDNA-plasmid pSDI-CL(NP), which should direct
transcription of a genomic-sense SDI-CL(NP) RNA, was transfected
into the cells. After 3 days, cell culture supernatants were harvested
and 1 ml was transferred on fresh BSR cells without additional HV.
Further passages were performed every 48 h, and mini-RNA-derived
gene expression was monitored by detection of luciferase activity in cell extracts. As shown in Fig. 6, rescue
of mini-RNA was successful in SAD Ambi-CAT-infected cells. Significant
luciferase activity was not detectable in the transfected cells but
appeared after passaging, demonstrating encapsidation of T7 RNA
polymerase transcripts into RNPs and DI particle formation. As
predicted from earlier experiments using a variety of monocistronic
mini-RNA analogs, no significant luciferase activity was detectable in
SAD L16-infected cells.

View larger version (37K):
[in this window]
[in a new window]
|
FIG. 6.
Mini-RNA rescue from cDNA by ambisense HV. T7 RNA
polymerase-expressing cells were infected with SAD Ambi-CAT or SAD L16
at an MOI of 1; 20 h postinfection pSDI-CL(NP), from which
negative-strand model RNA is transcribed by T7 RNA polymerase, was
transfected into the cells. After 3 days supernatants were transferred
on fresh BSR cells. Two further passage experiments were performed.
SDI-CL(NP)-derived gene expression was monitored by determining the
luciferase enzyme activities (relative light units) in cell extracts
prepared from transfected-infected cells. P1, P2, and P3, passages 1, 2, and 3.
|
|
 |
DISCUSSION |
Most DI RNAs interfere with the growth of parental viruses because
they are more successful in the competition for trans-acting factors required for replication, presumably the viral polymerase (17). This can be achieved, for example, by point mutations in promoter sequences (8) or the acquisition of new
promoters allowing more efficient polymerase binding and/or faster
initiation and elongation. As we have previously shown for RV,
competition between promoters of different strengths indeed represents
the physiological mechanism to maintain exact levels of
protein-encoding genome and replicative intermediate and to ensure
coordinated, optimal virus gene expression and virus propagation
(15). Such functional constraints do not apply to DI RNAs,
which are therefore rather free in promoter use. The overwhelming
amount of naturally occurring VSV and paramyxovirus DI particles
are 5' copy-back DI RNAs which contain two copies of the strong
parental AGP promoter (21, 22, 35, 37, 40). While the gain
of a second AGP provides a selective advantage in replication over the
parental virus, and also over internal deletion DI RNAs in mixed
infections (36), it is coupled with the loss of the GP and
the ability to transcribe mRNAs. Several internal deletion DIs RNAs
which have promoters derived from the parental GP and AGP and
which transcribe to various extents have also been found in
nature (1, 8, 13, 38). The more recent possibility of
constructing defective RNAs with exact copies of parental promoter
sequences, however, has confirmed that RV internal deletion constructs
(mini-RNAs) do not interfere with HV replication (9).
Rather than modifying the promoters of a mini-RNA, we have here used
another strategy to render it the phenotype of a DI RNA while
maintaining its capability for effective transcription and foreign gene
expression, namely, by providing an appropriate HV. The clue for this
was the availability of a nondeficient virus in which the
highly competitive AGP was replaced with the sequence of the GP
(15). Interestingly, this virus replicated efficiently, showing that it is the competition with the AGP that makes the GP weak.
We have shown here that the principle of competition between promoters
can be used for preferential amplification and gene expression of a
standard model RNA in an HV-dependent system.
Indeed, compared to wt RV, SAD Ambi-CAT and SAD Ambi supported up to
104-fold-higher luciferase expression from SDI-CL(NP).
A low level of luciferase expression in wt RV-infected cells, and
scarcely detectable Northern hybridization signals, showed that the
mini-RNA was also propagated by wt RV through the passages but was not amplified. As was previously observed for other internal deletion mini-RNAs (9), SDI-CL(NP) was completely lost after
slight dilution of the supernatants during passages (not shown). In
contrast, as indicated by high-level luciferase expression and
confirmed by Northern analyses, there was considerable interference of
SDI-CL(NP) with the replication of SAD Ambi-CAT.
Preferential amplification of DI RNAs is sometimes accompanied by
drastic interference with HV replication, leading to an depletion of
the virus protein supply. This might also shut down DI RNA replication,
especially when the initial amount of DI RNAs in infections is high
(3, 18, 29). In most cases, steeply oscillating titer curves
are observed over time, reflecting the interaction between HV and DI
RNA. The passage of SDI CL(NP), as monitored by luciferase
activities, occurred also in a somehow oscillatory manner but remained
at a high level throughout the six passages. Thus, the interference of
DI RNA with HV replication appeared moderate and more regulated,
leading to rather stable infections and constant levels of gene
expression throughout the passages.
The extent of interference with ambisense HV RNA replication was
analyzed by Northern hybridizations with RNA from cells and from
virions that were released into the cell culture supernatants. Since
the GP and AGP promoters of RV direct a ratio of genome and antigenome
RNA of 50:1, we concluded that the proportion of mini-RNA and HV RNAs
should at least not be less. Already in the second passage the ratio
was found to be greater than 50:1. Because the hybridization signal of
full-length SDI-CL(NP) in cell RNA is composed of viral RNA and
bicistronic readthrough transcripts and gave a 150-fold-higher value
than that of full-length HV RNA, the actual ratio was less than 150:1.
This ratio was further increased in the third passage. The total
amount of both mini-RNA and HV was found to be decreased, such that HV
RNA was hardly detectable and a reasonable direct determination of
ratios was not possible.
Remarkably, the ratio of mini-RNA and HV particles present in
cell culture supernatants was higher than that observed in cells. After the second passage, an approximately 240-fold dominance of DI particles was observed, compared to the maximal 150-fold dominance in cells. Since RV genome and antigenome RNAs are
incorporated equally well into virus envelopes (15), this
indicated that formation of SDI-CL(NP) particles occurs a bit more
efficiently than HV formation. This is consistent with previous work
indicating that budding of internally deleted Sendai virus RNPs
was positively influenced by decreasing RNP size (39).
However, increasing budding efficiencies with increasing RNP size were
also reported for Sendai virus internal deletion DI RNAs
(27). For Sendai virus 5' copy-back DI RNAs, it was
consistently observed that budding efficiency was negatively influenced
by small RNP sizes (27, 39). Thus, it remains unclear how
budding efficiency is correlated with the size of RNPs and whether
other factors may contribute to the ability of RNPs to be released
into the supernatant.
In view of the magnitude of interference, it was astonishing that the
low ambisense HV production was sufficient for allowing continuous
passaging of DI RNAs and high-level DI RNA-derived reporter gene
expression without additional HV. One factor contributing to this is
probably a high intracellular stability of viral RNPs. For VSV, it was
previously shown that the biological half-life of intracellular DI RNPs
was between 6 and 12.5 h (11). It was also shown for
measles virus and Sendai virus that defective RNPs remain quite stable
after infection of cells in the absence of HV (26). In cells
coinfected with few RV ambisense HV and many interfering mini-RNAs, a
high stability of RNPs might become an important factor allowing
long-term gene expression and for providing sufficient virus
proteins for RNA replication and for release of virus particles.
Another factor that might contribute is a delayed accumulation of
intracellular N protein in ambisense RV-DI RNA-infected cells.
According to the widely accepted view that the N protein concentration
is involved in determining the mode of RNA synthesis of negative-strand
RNA viruses, high amounts of soluble N protein should direct the viral
polymerase into the replication mode (2, 10, 33, 49). We
hypothesize that in SAD Ambi-SDI-CL(NP)-infected cells a relative
low level of N protein is available due to the competition between DI
RNA and HV for N protein and that this may be responsible for the
relatively high level transcription from both HV and mini-RNAs. The
transcription mode, which is not dependent on N protein supply, might
be favored or elongated at the expense of replication, which is N
dependent. Indeed, in cells coinfected with VSV and 5' copy-back DI
RNAs we observed a prolonged synthesis of viral proteins that resulted in slower accumulation of virus proteins and delayed release of both
virus and DI particles (47). Approaches can now be developed to investigate whether transcription and replication rates can be
influenced by a transcriptionally active DI RNA.
Finally, the most important factor responsible for maintaining
high-level gene expression in coinfected cells is the promoter composition of HV and DI RNAs. In RV-infected cells, the 50:1 bias of
genome and antigenome RNA is extreme in comparison with other
negative-strand RNA viruses. Even in the closely related rhabdovirus
VSV, only an approximately fourfold dominance of genome RNA over
antigenome RNA is observed in infected cells (44, 48), and
in the more distantly related Sendai virus 13 to 28% of cellular virus
full-length RNA is antigenome RNA (19). The relative
difference in promoter strength, which obviously must influence the
degree of interference of DI RNAs with HV, should be reflected by the DI biology in the different virus systems. The most atypical behavior in this respect is indeed exhibited by RV. In striking contrast to VSV
and paramyxovirus infections, where 5' copy-back DI RNAs are readily
amplified after undiluted passaging, this is not observed for RV.
Indeed, all natural RV DI RNAs that we have obtained and analyzed so
far are of the internal deletion type (reference 8 and unpublished results). This observation introduces the idea that the
interference of putative RV 5' copy-back DI RNAs which have two strong
AGPs with HV replication may be so pronounced that HV infection is
completely shut down. As verified by hybridization experiments with
strand-specific probes, SDI-CL(NP) virions contain abundant amounts
of negative-strand RNA (not shown). Newly coinfected cells should
thus contain equal levels of HV genome and antigenome RNPs and high
amounts of negative-strand DI RNA. Only upon the first steps of
replication does the strong AGP of the DI antigenome become available
and able to enter in the competition for polymerase. Thus, a moderate
degree of interference especially in the early stage of infection may
allow HV the opportunity for propagation. In contrast, in the case of
5' copy-back DI RNAs, the strongly interfering AGP is available from
the initiation of infection. Moreover, the hot start of 5' copy-back DI
RNAs immediately initiates the exponential phase of amplification,
since both strands possess the competitive AGP promoters, so that HV
replication may be rapidly suppressed to insufficient levels.
We have also exploited the features of ambisense RV to provide evidence
that recovery of a rhabdovirus genome analog from cDNA is possible in
an HV-driven support system. So far, rescue has been demonstrated after
coexpression of support proteins N, P, and L from transfected DNA,
mostly by using the transient vaccinia virus T7 RNA polymerase
expression system (9, 32), but not in rhabdovirus-infected
cells. This is in striking contrast to the situation in
paramyxoviruses, where expression of genome-analogous RNAs in
virus-infected cells faithfully resulted in rescue into RNPs, mini-RNA
gene expression, and formation of passageable particles (6, 12,
30, 43). Encapsidation of naked SDI-CL(NP) RNA in ambisense
HV-infected cells was possible but was very inefficient, as no specific
reporter gene activity was found in the transfected cells. In the case
of paramyxovirus helper-driven rescue, this is readily observed in most
cases. Enzyme activity was detectable only after passaging and rose
rapidly, owing to the competition of SDI-CL(NP) RNPs with ambisense
HV, while no detectable activity was found with SAD L16 virus. A few
SDI-CL(NP) RNPs might also be formed after transfection of SAD
L16-infected cells, as the levels of N protein are comparable in SAD
Ambi- and SAD L16-infected cells. Since the newly formed RNPs are not
selectively amplified by SAD L16, HV rescue appears to fail. However,
it cannot be ruled out that efficiencies of encapsidation of T7 RNA
polymerase transcripts are different in SAD Ambi- and in SAD
L16-infected cells. Competition between promoter sequences may occur at
the encapsidation step. This may be caused by a high N binding activity
of the standard virus's AGP, such that in SAD L16-infected cells a
lower amount of N protein is available for illegitimate encapsidation
of T7 transcripts.
The described infection system making use of a nondefective ambisense
virus and a transcriptionally active mini-RNA combines the principles
of DI interference and effective gene expression, as described
previously for a wt Sendai virus that also amplified transcriptionally
active mini-RNAs (25). The rather moderate degree of
interference allows fairly stable infection conditions. Preferential
amplification to a certain degree of SDI-CL(NP) RNPs led to the
accumulation of high amounts of the desired templates. These RNP
templates competed with the HV RNPs also in transcription, leading to
high-level expression of the mini-RNA-encoded genes. This combination
is superior to nondeficient RV vectors. Besides offering the
possibility of efficient foreign gene expression, the system also may
considerably enhance the total capacity of RV for additional genes.
Although a size limit for integration of additional sequences is not
yet defined for any nonsegmented negative-strand RNA virus, one can
expect that greatly increasing the length of at least 12-kb full-length
constructs reduces the recovery rate. Thus, defective RNAs that contain
only 237 nucleotides of the RV terminal sequences seem to be the choice
for integration of large foreign sequences. What makes this approach
even more attractive and powerful is the possibility that the
respective cDNA constructs are reproducibly rescued by the ambisense HV
after transfection into the newly established BSR T7/5 cells expressing T7 RNA polymerase.
 |
ACKNOWLEDGMENT |
This work was supported by grant BEO 031171 from BMBF.
 |
FOOTNOTES |
*
Corresponding author. Present address: Max von
Pettenkofer Institut, Genzentrum, Feodor-Lynen-Str. 25, D-81377 Munich,
Germany. Phone: 49 089 74017201. Fax: 49 089 74017250. E-mail:
conzelma{at}lmb.uni-muenchen.de.
 |
REFERENCES |
| 1.
|
Amesse, L. S.,
C. L. Pridgen, and D. W. Kingsbury.
1982.
Sendai virus DI RNA species with conserved virus genome termini and extensive internal deletions.
Virology
118:17-27[Medline].
|
| 2.
|
Arnheiter, H.,
N. L. Davis,
G. Wertz,
M. Schubert, and R. A. Lazzarini.
1985.
Role of the nucleocapsid protein in regulating vesicular stomatitis virus RNA synthesis.
Cell
41:259-267[Medline].
|
| 3.
|
Bangham, C. R., and T. B. Kirkwood.
1990.
Defective interfering particles: effects in modulating virus growth and persistence.
Virology
179:821-826[Medline].
|
| 4.
|
Buchholz, U.,
S. Finke, and K.-K. Conzelmann.
1999.
Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in vitro and the human RSV leader region acts as a functional BRSV genome promoter.
J. Virol.
73:251-259[Abstract/Free Full Text].
|
| 5.
|
Calain, P., and L. Roux.
1995.
Functional characterisation of the genomic and antigenomic promoters of Sendai virus.
Virology
212:163-173[Medline].
|
| 6.
|
Collins, P. L.,
M. A. Mink, and D. S. Stec.
1991.
Rescue of synthetic analogs of respiratory syncytial virus genomic RNA and effect of truncations and mutations on the expression of a foreign reporter gene.
Proc. Natl. Acad. Sci. USA
88:9663-9667[Abstract/Free Full Text].
|
| 7.
|
Conzelmann, K. K.,
J. H. Cox,
L. G. Schneider, and H. J. Thiel.
1990.
Molecular cloning and complete nucleotide sequence of the attenuated rabies virus SAD B19.
Virology
175:485-499[Medline].
|
| 8.
|
Conzelmann, K. K.,
J. H. Cox, and H. J. Thiel.
1991.
An L (polymerase)-deficient rabies virus defective interfering particle RNA is replicated and transcribed by heterologous helper virus L proteins.
Virology
184:655-663[Medline].
|
| 9.
|
Conzelmann, K. K., and M. Schnell.
1994.
Rescue of synthetic genomic RNA analogs of rabies virus by plasmid-encoded proteins.
J. Virol.
68:713-719[Abstract/Free Full Text].
|
| 10.
|
Davis, N. L., and G. W. Wertz.
1982.
Synthesis of vesicular stomatitis virus negative-strand RNA in vitro: dependence on viral protein synthesis.
J. Virol.
41:821-832[Abstract/Free Full Text].
|
| 11.
|
DePolo, N. J., and J. J. Holland.
1986.
The intracellular half-lives of nonreplicating nucleocapsids of DI particles of wild type and mutant strains of vesicular stomatitis virus.
Virology
151:371-378[Medline].
|
| 12.
|
Dimock, K., and P. L. Collins.
1993.
Rescue of synthetic analogs of genomic RNA and replicative-intermediate RNA of human parainfluenza virus type 3.
J. Virol.
67:2772-2778[Abstract/Free Full Text].
|
| 13.
|
Engelhorn, M.,
R. Stricker, and L. Roux.
1993.
Molecular cloning and characterization of a Sendai virus internal deletion defective RNA.
J. Gen. Virol.
74:137-141[Abstract/Free Full Text].
|
| 14.
|
Fearns, R.,
M. E. Peeples, and P. L. Collins.
1997.
Increased expression of the N protein of respiratory syncytial virus stimulates minigenome replication but does not alter the balance between the synthesis of mRNA and antigenome.
Virology
236:188-201[Medline].
|
| 15.
|
Finke, S., and K. K. Conzelmann.
1997.
Ambisense gene expression from recombinant rabies virus: random packaging of positive- and negative-strand ribonucleoprotein complexes into rabies virions.
J. Virol.
71:7281-7288[Abstract].
|
| 16.
|
Fuerst, T. R.,
E. G. Niles,
F. W. Studier, and B. Moss.
1986.
Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase.
Proc. Natl. Acad. Sci. USA
83:8122-8126[Abstract/Free Full Text].
|
| 17.
|
Giachetti, C., and J. J. Holland.
1989.
Vesicular stomatitis virus and its defective interfering particles exhibit in vitro transcriptional and replicative competition for purified L-NS polymerase molecules.
Virology
170:264-267[Medline].
|
| 18.
|
Grabau, E. A., and J. J. Holland.
1982.
Analysis of viral and defective-interfering nucleocapsids in acute and persistent infection by rhabdoviruses.
J. Gen. Virol.
60:87-97[Abstract/Free Full Text].
|
| 19.
|
Kolakofsky, D., and A. Bruschi.
1975.
Antigenomes in Sendai virions and Sendai virus-infected cells.
Virology
66:185-191[Medline].
|
| 20.
|
Kuo, L.,
H. Grosfeld,
J. Cristina,
M. G. Hill, and P. L. Collins.
1996.
Effects of mutations in the gene-start and gene-end sequence motifs on transcription of monocistronic and dicistronic minigenomes of respiratory syncytial virus.
J. Virol.
70:6892-6901[Abstract/Free Full Text].
|
| 21.
|
Lazzarini, R. A.,
J. D. Keene, and M. Schubert.
1981.
The origins of defective interfering particles of the negative-strand RNA viruses.
Cell
26:145-154[Medline].
|
| 22.
|
Leppert, M.,
L. Kort, and D. Kolakofsky.
1977.
Further characterization of Sendai virus DI-RNAs: a model for their generation.
Cell
12:539-552[Medline].
|
| 23.
|
Li, T., and A. K. Pattnaik.
1997.
Replication signals in the genome of vesicular stomatitis virus and its defective interfering particles: identification of a sequence element that enhances DI RNA replication.
Virology
232:248-259[Medline].
|
| 24.
|
Mebatsion, T.,
M. J. Schnell,
J. H. Cox,
S. Finke, and K. K. Conzelmann.
1996.
Highly stable expression of a foreign gene from rabies virus vectors.
Proc. Natl. Acad. Sci. USA
93:7310-7314[Abstract/Free Full Text].
|
| 25.
|
Mottet, G.,
A. Muhlemann,
C. Tapparel,
F. Hoffmann, and L. Roux.
1996.
A Sendai virus vector leading to the efficient expression of mutant M proteins interfering with virus particle budding.
Virology
221:159-171[Medline].
|
| 26.
|
Mottet, G.,
J. Curran, and L. Roux.
1990.
Intracellular stability of nonreplicating paramyxovirus nucleocapsids.
Virology
176:1-7[Medline].
|
| 27.
|
Mottet, G., and L. Roux.
1989.
Budding efficiency of Sendai virus nucleocapsids: influence of size and ends of the RNA.
Virus Res.
14:175-187[Medline].
|
| 28.
|
Murphy, S. K.,
Y. Ito, and G. D. Parks.
1998.
A functional antigenomic promoter for the paramyxovirus simian virus 5 requires proper spacing between an essential internal segment and the 3' terminus.
J. Virol.
72:10-19[Abstract/Free Full Text].
|
| 29.
|
Palma, E. L., and A. Huang.
1974.
Cyclic production of vesicular stomatitis virus caused by defective interfering particles.
J. Infect. Dis.
129:402-410[Medline].
|
| 30.
|
Park, K. H.,
T. Huang,
F. F. Correia, and M. Krystal.
1991.
Rescue of a foreign gene by Sendai virus.
Proc. Natl. Acad. Sci. USA
88:5537-5541[Abstract/Free Full Text].
|
| 31.
|
Pattnaik, A. K.,
L. A. Ball,
A. LeGrone, and G. W. Wertz.
1995.
The termini of VSV DI particle RNAs are sufficient to signal RNA encapsidation, replication, and budding to generate infectious particles.
Virology
206:760-764[Medline].
|
| 32.
|
Pattnaik, A. K.,
L. A. Ball,
A. W. LeGrone, and G. W. Wertz.
1992.
Infectious defective interfering particles of VSV from transcripts of a cDNA clone.
Cell
69:1011-1020[Medline].
|
| 33.
|
Patton, J. T.,
N. L. Davis, and G. W. Wertz.
1984.
N protein alone satisfies the requirement for protein synthesis during RNA replication of vesicular stomatitis virus.
J. Virol.
49:303-309[Abstract/Free Full Text].
|
| 34.
|
Pelet, T.,
C. Delenda,
O. Gubbay,
D. Garcin, and D. Kolakofsky.
1996.
Partial characterization of a Sendai virus replication promoter and the rule of six.
Virology
224:405-414[Medline].
|
| 35.
|
Perrault, J.
1981.
Origin and replication of defective interfering particles.
Curr. Top. Microbiol. Immunol.
93:151-207[Medline].
|
| 36.
|
Perrault, J., and B. L. Semler.
1979.
Internal genome deletions in two distinct classes of defective interfering particles of vesicular stomatitis virus.
Proc. Natl. Acad. Sci. USA
76:6191-6195[Abstract/Free Full Text].
|
| 37.
|
Rao, D. D., and A. S. Huang.
1982.
Interference among defective interfering particles of vesicular stomatitis virus.
J. Virol.
41:210-221[Abstract/Free Full Text].
|
| 38.
|
Re, G. G.,
K. C. Gupta, and D. W. Kingsbury.
1983.
Genomic and copy-back 3' termini in Sendai virus defective interfering RNA species.
J. Virol.
45:659-664[Abstract/Free Full Text].
|
| 39.
|
Re, G. G., and D. W. Kingsbury.
1988.
Paradoxical effects of Sendai virus DI RNA size on survival: inefficient envelopment of small nucleocapsids.
Virology
165:331-337[Medline].
|
| 40.
|
Schlesinger, S.
1988.
The generation and amplification of defective interfering RNAs, p. 167-184.
In
E. Domingo, J. J. Holland, and P. Ahlquist (ed.), RNA genetics. CRC Press Inc., Boca Raton, Fla.
|
| 41.
|
Schnell, M. J., and K. K. Conzelmann.
1995.
Polymerase activity of in vitro mutated rabies virus L protein.
Virology
214:522-530[Medline].
|
| 42.
|
Schnell, M. J.,
T. Mebatsion, and K. K. Conzelmann.
1994.
Infectious rabies viruses from cloned cDNA.
EMBO J.
13:4195-4203[Medline].
|
| 43.
|
Sidhu, M. S.,
J. Chan,
K. Kaelin,
P. Spielhofer,
F. Radecke,
H. Schneider,
M. Masurekar,
P. C. Dowling,
M. A. Billeter, and S. A. Udem.
1995.
Rescue of synthetic measles virus minireplicons: measles genomic termini direct efficient expression and propagation of a reporter gene.
Virology
208:800-807[Medline].
|
| 44.
|
Soria, M.,
S. P. Little, and A. S. Huang.
1974.
Characterization of vesicular stomatitis virus nucleocapsids. I. Complementary 40 S RNA molecules in nucleocapsids.
Virology
61:270-280[Medline].
|
| 45.
|
Tapparel, C.,
D. Maurice, and L. Roux.
1998.
The activity of Sendai virus genomic and antigenomic promoters requires a second element past the leader template regions: a motif (GNNNNN)3 is essential for replication.
J. Virol.
72:3117-3128[Abstract/Free Full Text].
|
| 46.
|
Tapparel, C., and L. Roux.
1996.
The efficiency of Sendai virus genome replication: the importance of the RNA primary sequence independent of terminal complementarity.
Virology
225:163-171[Medline].
|
| 47.
|
Von Laer, D. M.,
D. Mack, and J. Kruppa.
1988.
Delayed formation of defective interfering particles in vesicular stomatitis virus-infected cells: kinetic studies of viral protein and RNA synthesis during autointerference.
J. Virol.
62:1323-1329[Abstract/Free Full Text].
|
| 48.
|
Wertz, G. W.
1978.
Isolation of possible replicative intermediate structures from vesicular stomatitis virus-infected cells.
Virology
85:271-285[Medline].
|
| 49.
|
Wertz, G. W., and M. Levine.
1973.
RNA synthesis by vesicular stomatitis virus and a small plaque mutant: effects of cycloheximide.
J. Virol.
12:253-264[Abstract/Free Full Text].
|
Journal of Virology, May 1999, p. 3818-3825, Vol. 73, No. 5
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Klingen, Y., Conzelmann, K.-K., Finke, S.
(2008). Double-Labeled Rabies Virus: Live Tracking of Enveloped Virus Transport. J. Virol.
82: 237-245
[Abstract]
[Full Text]
-
Marston, D. A., McElhinney, L. M., Johnson, N., Muller, T., Conzelmann, K. K., Tordo, N., Fooks, A. R.
(2007). Comparative analysis of the full genome sequence of European bat lyssavirus type 1 and type 2 with other lyssaviruses and evidence for a conserved transcription termination and polyadenylation motif in the G-L 3' non-translated region. J. Gen. Virol.
88: 1302-1314
[Abstract]
[Full Text]
-
Plesa, G., McKenna, P. M., Schnell, M. J., Eisenlohr, L. C.
(2006). Immunogenicity of cytopathic and noncytopathic viral vectors.. J. Virol.
80: 6259-6266
[Abstract]
[Full Text]
-
Brzozka, K., Finke, S., Conzelmann, K.-K.
(2005). Identification of the Rabies Virus Alpha/Beta Interferon Antagonist: Phosphoprotein P Interferes with Phosphorylation of Interferon Regulatory Factor 3. J. Virol.
79: 7673-7681
[Abstract]
[Full Text]
-
Rosario, D., Perez, M., de la Torre, J. C.
(2005). Functional Characterization of the Genomic Promoter of Borna Disease Virus (BDV): Implications of 3'-Terminal Sequence Heterogeneity for BDV Persistence. J. Virol.
79: 6544-6550
[Abstract]
[Full Text]
-
Finke, S., Brzozka, K., Conzelmann, K.-K.
(2004). Tracking Fluorescence-Labeled Rabies Virus: Enhanced Green Fluorescent Protein-Tagged Phosphoprotein P Supports Virus Gene Expression and Formation of Infectious Particles. J. Virol.
78: 12333-12343
[Abstract]
[Full Text]
-
McKenna, P. M., Pomerantz, R. J., Dietzschold, B., McGettigan, J. P., Schnell, M. J.
(2003). Covalently Linked Human Immunodeficiency Virus Type 1 gp120/gp41 Is Stably Anchored in Rhabdovirus Particles and Exposes Critical Neutralizing Epitopes. J. Virol.
77: 12782-12794
[Abstract]
[Full Text]
-
Finke, S., Conzelmann, K.-K.
(2003). Dissociation of Rabies Virus Matrix Protein Functions in Regulation of Viral RNA Synthesis and Virus Assembly. J. Virol.
77: 12074-12082
[Abstract]
[Full Text]
-
McGettigan, J. P., Naper, K., Orenstein, J., Koser, M., McKenna, P. M., Schnell, M. J.
(2003). Functional Human Immunodeficiency Virus Type 1 (HIV-1) Gag-Pol or HIV-1 Gag-Pol and Env Expressed from a Single Rhabdovirus-Based Vaccine Vector Genome. J. Virol.
77: 10889-10899
[Abstract]
[Full Text]
-
Bossert, B., Marozin, S., Conzelmann, K.-K.
(2003). Nonstructural Proteins NS1 and NS2 of Bovine Respiratory Syncytial Virus Block Activation of Interferon Regulatory Factor 3. J. Virol.
77: 8661-8668
[Abstract]
[Full Text]
-
Finke, S., Mueller-Waldeck, R., Conzelmann, K.-K.
(2003). Rabies virus matrix protein regulates the balance of virus transcription and replication. J. Gen. Virol.
84: 1613-1621
[Abstract]
[Full Text]
-
McGettigan, J. P., Pomerantz, R. J., Siler, C. A., McKenna, P. M., Foley, H. D., Dietzschold, B., Schnell, M. J.
(2002). Second-Generation Rabies Virus-Based Vaccine Vectors Expressing Human Immunodeficiency Virus Type 1 Gag Have Greatly Reduced Pathogenicity but Are Highly Immunogenic. J. Virol.
77: 237-244
[Abstract]
[Full Text]
-
Neumann, G., Whitt, M. A., Kawaoka, Y.
(2002). A decade after the generation of a negative-sense RNA virus from cloned cDNA - what have we learned?. J. Gen. Virol.
83: 2635-2662
[Abstract]
[Full Text]
-
Bossert, B., Conzelmann, K.-K.
(2002). Respiratory Syncytial Virus (RSV) Nonstructural (NS) Proteins as Host Range Determinants: a Chimeric Bovine RSV with NS Genes from Human RSV Is Attenuated in Interferon-Competent Bovine Cells. J. Virol.
76: 4287-4293
[Abstract]
[Full Text]
-
Schlender, J., Walliser, G., Fricke, J., Conzelmann, K.-K.
(2002). Respiratory Syncytial Virus Fusion Protein Mediates Inhibition of Mitogen-Induced T-Cell Proliferation by Contact. J. Virol.
76: 1163-1170
[Abstract]
[Full Text]
-
Foley, H. D., Otero, M., Orenstein, J. M., Pomerantz, R. J., Schnell, M. J.
(2002). Rhabdovirus-Based Vectors with Human Immunodeficiency Virus Type 1 (HIV-1) Envelopes Display HIV-1-Like Tropism and Target Human Dendritic Cells. J. Virol.
76: 19-31
[Abstract]
[Full Text]
-
Marriott, A. C., Smith, J. M., Easton, A. J.
(2001). Fidelity of Leader and Trailer Sequence Usage by the Respiratory Syncytial Virus and Avian Pneumovirus Replication Complexes. J. Virol.
75: 6265-6272
[Abstract]
[Full Text]
-
Foley, H. D., McGettigan, J. P., Siler, C. A., Dietzschold, B., Schnell, M. J.
(2000). A recombinant rabies virus expressing vesicular stomatitis virus glycoprotein fails to protect against rabies virus infection. Proc. Natl. Acad. Sci. USA
10.1073/pnas.011510698v1
[Abstract]
[Full Text]
-
Schlender, J., Bossert, B., Buchholz, U., Conzelmann, K.-K.
(2000). Bovine Respiratory Syncytial Virus Nonstructural Proteins NS1 and NS2 Cooperatively Antagonize Alpha/Beta Interferon-Induced Antiviral Response. J. Virol.
74: 8234-8242
[Abstract]
[Full Text]
-
Finke, S., Cox, J. H., Conzelmann, K.-K.
(2000). Differential Transcription Attenuation of Rabies Virus Genes by Intergenic Regions: Generation of Recombinant Viruses Overexpressing the Polymerase Gene. J. Virol.
74: 7261-7269
[Abstract]
[Full Text]
-
Fearns, R., Collins, P. L., Peeples, M. E.
(2000). Functional Analysis of the Genomic and Antigenomic Promoters of Human Respiratory Syncytial Virus. J. Virol.
74: 6006-6014
[Abstract]
[Full Text]
-
Foley, H. D., McGettigan, J. P., Siler, C. A., Dietzschold, B., Schnell, M. J.
(2000). A recombinant rabies virus expressing vesicular stomatitis virus glycoprotein fails to protect against rabies virus infection. Proc. Natl. Acad. Sci. USA
97: 14680-14685
[Abstract]
[Full Text]
-
Schnell, M. J., Foley, H. D., Siler, C. A., McGettigan, J. P., Dietzschold, B., Pomerantz, R. J.
(2000). Recombinant rabies virus as potential live-viral vaccines for HIV-1. Proc. Natl. Acad. Sci. USA
97: 3544-3549
[Abstract]
[Full Text]